JR-441
JR-441-101
Phase 1 small_molecule active
Quick answer
JR-441 for Mucopolysaccharidosis type IIIA (MPS IIIA) is a Phase 1 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Mucopolysaccharidosis type IIIA (MPS IIIA)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active